Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Tejpar

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Best Practice & Research. Clinical Gastroenterology|December 12, 2007
The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancerSabine Tejpar
Clinical Advances in Hematology & Oncology : H&O|August 16, 2011
Biomarkers to predict response to anti-EGFR antibodiesSabine Tejpar
Asia-Pacific Journal of Clinical Oncology|February 12, 2014
Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: a future opportunity?Sabine Tejpar, Hubert Piessevaux
Public Health Genomics|November 20, 2015
Charting the Course for a New Cancer Clinical Research CultureSabine Tejpar, Roberto Salgado,
JAMA Oncology|January 16, 2016
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer: Requirements for Accurate Prognosis AssessmentDirk Klingbiel, Sabine Tejpar
Lancet (London, England)|November 15, 2025
The dawn of immunotherapy in mismatch repair proficient colorectal cancerGertjan Rasschaert, Sabine Tejpar
Gastrointestinal Cancer Research : GCR|December 17, 2009
Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancerSabine Tejpar, Robert D Odze
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
Molecular and genetic defects in colorectal tumorigenesisSabine Tejpar, Eric Van Cutsem
Targeted Oncology|November 17, 2009
Implications of KRAS mutation status for the treatment of metastatic colorectal cancerFortunato Ciardiello, Sabine Tejpar, Demetris Papamichael
Advances in Experimental Medicine and Biology|February 15, 2018
Deregulation of ZIC Family Members in OncogenesisRob Houtmeyers, Jabob Souopgui, Sabine Tejpar
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Best Practice & Research. Clinical Gastroenterology|December 12, 2007
The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancerSabine Tejpar
Clinical Advances in Hematology & Oncology : H&O|August 16, 2011
Biomarkers to predict response to anti-EGFR antibodiesSabine Tejpar
Asia-Pacific Journal of Clinical Oncology|February 12, 2014
Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: a future opportunity?Sabine Tejpar, Hubert Piessevaux
Public Health Genomics|November 20, 2015
Charting the Course for a New Cancer Clinical Research CultureSabine Tejpar, Roberto Salgado,
JAMA Oncology|January 16, 2016
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer: Requirements for Accurate Prognosis AssessmentDirk Klingbiel, Sabine Tejpar
Lancet (London, England)|November 15, 2025
The dawn of immunotherapy in mismatch repair proficient colorectal cancerGertjan Rasschaert, Sabine Tejpar
Gastrointestinal Cancer Research : GCR|December 17, 2009
Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancerSabine Tejpar, Robert D Odze
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
Molecular and genetic defects in colorectal tumorigenesisSabine Tejpar, Eric Van Cutsem
Targeted Oncology|November 17, 2009
Implications of KRAS mutation status for the treatment of metastatic colorectal cancerFortunato Ciardiello, Sabine Tejpar, Demetris Papamichael
Advances in Experimental Medicine and Biology|February 15, 2018
Deregulation of ZIC Family Members in OncogenesisRob Houtmeyers, Jabob Souopgui, Sabine Tejpar
Pageof 24